Chelsea Therapeutics to Present at the 25th Annual ROTH Conference
March 12, 2013 07:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 12, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 25TH Annual ROTH Conference at 3:30 PM PT on Tuesday, March...
Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2012 Results
March 07, 2013 16:17 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 7, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year ended December 31,...
Chelsea Therapeutics Receives FDA Guidance for a Northera(TM) (Droxidopa) NDA Resubmission With Study 306B
February 20, 2013 07:00 ET
|
Chelsea Therapeutics
Company to Resubmit NDA in Late Second Quarter 2013
Short-term Clinical Benefit Adequate to Support Approval
Company to Host Conference Call Today at 9:00 AM ET
CHARLOTTE,...
Chelsea Therapeutics Announces Northera(TM) (Droxidopa) Study 306B Meets Primary Endpoint
December 04, 2012 16:05 ET
|
Chelsea Therapeutics
Northera™ Demonstrated Statistically Significant Improvement Over Placebo in Reduction of Dizziness/Lightheadedness at Week 1 (p=0.018), the Primary Endpoint, and Standing Blood Pressure at...
Chelsea Therapeutics Reports Third Quarter 2012 Financial Results
November 07, 2012 16:16 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the quarter and nine months ended September 30,...
Chelsea Therapeutics Announces Results From Northera(TM) (droxidopa) Study in Spinal Cord Injury at the 23rd International Symposium on the Autonomic Nervous System
November 06, 2012 08:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced results from a study of Northera™ (droxidopa) in hypotensive individuals...
Chelsea Therapeutics to Present at the 14th Annual Rodman & Renshaw Global Healthcare Investment Conference
September 04, 2012 08:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 14th Annual Rodman & Renshaw Global Healthcare Investment...
Chelsea Therapeutics to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference
August 08, 2012 08:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference...
Chelsea Therapeutics Reports Second Quarter 2012 Financial Results
August 07, 2012 16:13 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the quarter and six months ended June 30, 2012.
For the...
Chelsea Therapeutics to Implement Corporate Reorganization
July 10, 2012 06:45 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 10, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that its Board of Directors plans to promptly implement a corporate...